JULIE PARK: Open Payments
NPI 1235320516 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 17 payments from 12 companies in 2025. Trend: 2023 $1,726 · 2024 $1,449 · 2025 $828
Food & beverage: $729Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $333 |
| Merck Sharp & Dohme LLC | 2 | $133 |
| BeOne Medicines USA, Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Genmab U.S., Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $23 |
Products named: RYBREVANT, KEYTRUDA, BRUKINSA, TALVEY, ENHERTU, Epkinly, ICLUSIG, SCEMBLIX.
Industry payments across VA — which companies pay providers there.
